Snowden Capital Advisors’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,360
Closed -$224K 1179
2023
Q1
$224K Buy
5,360
+8
+0.1% +$337 0.01% 1042
2022
Q4
$233K Buy
5,352
+8
+0.1% +$340 0.01% 1013
2022
Q3
$207K Buy
5,344
+8
+0.1% +$341 0.01% 1023
2022
Q2
$226K Buy
5,336
+10
+0.2% +$434 0.01% 989
2022
Q1
$242K Buy
5,326
+3,476
+188% +$154K 0.01% 904
2021
Q4
$89K Buy
+1,850
New +$87.6K ﹤0.01% 875

Other funds holding BME

Snowden Capital Advisors's BME Position: Q2 2023 in Review

Snowden Capital Advisors sold out of BlackRock Health Sciences Trust (BME) in Q2 2023, closing a stake of 5,360 shares — an estimated $224K sold.

Snowden Capital Advisors first reported a position in BME in Q4 2021 and held it in 6 quarters. The position peaked at $242K in Q1 2022. 69 funds tracked by Wall St. Rank hold BME as of Q2 2023.

  • Snowden Capital Advisors reported no remaining BlackRock Health Sciences Trust position as of Q2 2023 after selling out during the quarter.
  • Snowden Capital Advisors sold 5,360 BlackRock Health Sciences Trust shares in Q2 2023, an estimated $224K.
  • Snowden Capital Advisors first reported a position in BlackRock Health Sciences Trust in Q4 2021 and held it in 6 quarters.
  • Snowden Capital Advisors's BlackRock Health Sciences Trust position peaked at $242K in Q1 2022.
  • 69 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2023.

Based on Snowden Capital Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.